Orthofix International reported $873.02M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.07B 188.78M Jun/2026
AtriCure USD 676.64M 32.66M Jun/2026
Dexcom USD 6.46B 178M Jun/2026
EDAP TMS EUR 72.06M 10.6M Mar/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
J&J USD 201.06B 167M Jun/2026
Medtronic USD 91.48B 139M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 873.02M 13.58M Jun/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026
STAAR Surgical USD 475.2M 24.09M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
Veracyte USD 1.49B 49.97M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026